Penumbra (PEN) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US70975L1070
Penumbra, Inc. (NYSE: PEN) is a company that designs, develops, manufactures, and sells medical devices both in the United States and worldwide. They have a wide range of products serving various medical needs.
Some of the products they offer are aspiration based thrombectomy systems for both peripheral and neuro procedures, neurovascular embolization coiling systems, access products, and peripheral embolization products.
Moreover, Penumbra, Inc. provides advanced 3D computer technology platforms and neurosurgical tools aimed at enhancing medical procedures and patient care.
The company distributes its products through direct sales organizations and a network of distributors, ensuring broad access to their innovative medical devices.
Established in 2004, Penumbra, Inc. is headquartered in Alameda, California. For more information, you can visit their website at https://www.penumbrainc.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
PEN Stock Overview
Market Cap in USD | 8,638m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2015-09-18 |
PEN Stock Ratings
Growth 5y | 2.22 |
Fundamental | 5.46 |
Dividend | - |
Rel. Performance vs Sector | -3.34 |
Analysts | 4.38/5 |
Fair Price Momentum | 164.56 USD |
Fair Price DCF | 53.28 USD |
PEN Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
PEN Growth Ratios
Growth 12m | -26.66% |
Growth Correlation 12m | -45% |
Growth Correlation 3m | -62% |
CAGR 5y | 9.19% |
Sharpe Ratio 12m | -0.78 |
Alpha vs SP500 12m | -54.65 |
Beta vs SP500 5y weekly | 1.28 |
ValueRay RSI | 17.15 |
Volatility GJR Garch 1y | 41.82% |
Price / SMA 50 | -14.77% |
Price / SMA 200 | -17.91% |
Current Volume | 330.4k |
Average Volume 20d | 342.6k |
External Links for PEN Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 20, 2024, the stock is trading at USD 201.84 with a total of 330,440 shares traded.
Over the past week, the price has changed by -9.27%, over one month by -13.88%, over three months by -21.10% and over the past year by -25.67%.
According to ValueRays Forecast Model, PEN Penumbra will be worth about 184.6 in April 2025. The stock is currently trading at 201.84. This means that the stock has a potential downside of -8.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 279.2 | 38.3% |
Analysts Target Price | 255.5 | 26.6% |
ValueRay Target Price | 184.6 | -8.53% |